Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Wilms Tumor × Busulfan × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 68 Leukemia 56 Myelodysplastic Syndromes 53 Lymphoma 47 Precursor Cell Lymphoblastic Leukemia-Lymphoma 46 Lymphoma, Non-Hodgkin 43 Multiple Myeloma 40 Hodgkin Disease 39 Leukemia, Lymphocytic, Chronic, B-Cell 35 Congenital Abnormalities 30 Lymphoma, Follicular 28 Lymphoma, Large B-Cell, Diffuse 27 Lymphoma, Mantle-Cell 26 Neoplasms, Plasma Cell 25 Lymphoma, B-Cell, Marginal Zone 24 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23 Burkitt Lymphoma 23 Myeloproliferative Disorders 22 Lymphoma, Large-Cell, Immunoblastic 22 Leukemia, Myelomonocytic, Chronic 22 Blast Crisis 22 Leukemia, Myeloid, Chronic-Phase 21 Leukemia, Myeloid, Accelerated Phase 21 Primary Myelofibrosis 19 Lymphoma, T-Cell, Cutaneous 15 Hematologic Neoplasms 15 Graft vs Host Disease 15 Dendritic Cell Sarcoma, Interdigitating 14 Anemia, Refractory, with Excess of Blasts 14 Waldenstrom Macroglobulinemia 13

Interventions

X-Rays 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 Phantoms, Imaging 5 Vincristine 4 Nuclear Medicine Department, Hospital 4 Doxorubicin 4 Dactinomycin 4 Radiotherapy 3 Biopsy 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 olaparib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 Vemurafenib 2 Radiotherapy, Conformal 2 Radiation 2 LY3023414 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 thymoglobulin 1 sargramostim 1 pembrolizumab 1 lorvotuzumab mertansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡